Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Equity (2020 - 2025)

Historic Return on Equity for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 0.2%.

  • Harmony Biosciences Holdings' Return on Equity changed 0.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.21% for FY2024, which is 600.0% down from last year.
  • Harmony Biosciences Holdings' Return on Equity amounted to 0.2% in Q3 2025, which was down 0.0% from 0.2% recorded in Q2 2025.
  • Harmony Biosciences Holdings' Return on Equity's 5-year high stood at 0.51% during Q3 2022, with a 5-year trough of 0.08% in Q3 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' median Return on Equity value was 0.2% (recorded in 2025), while the average stood at 0.26%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 5700bps in 2021, then tumbled by -2400bps in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Return on Equity (Quarter) stood at 0.18% in 2021, then surged by 166bps to 0.49% in 2022, then tumbled by -50bps to 0.24% in 2023, then fell by -23bps to 0.19% in 2024, then increased by 5bps to 0.2% in 2025.
  • Its Return on Equity stands at 0.2% for Q3 2025, versus 0.2% for Q2 2025 and 0.18% for Q1 2025.